AMI Briefing - AMR case study on the impact of COVID-19

Antimicrobial resistance (AMR) is not a new problem; bacteria have been evolving resistance to these essential drugs since we first began using them. AMR has not paused during the COVID-19 pandemic,
although it has been overshadowed, and there are many ways in which the pandemic could shape this problem now and in the future.